Discovery Medicine
The clinical application of rituximab (chimeric mouse anti-human CD20 mAb, Rituxan, IDEC-C2B8), alone and/or combined with chemotherapy, has significantly ameliorated the treatment outcome of patients with relapsed and refractory low-grade or follicular non-Hodgkin's lymphoma (NHL). The exact in ...
Kidney Problems:especially if you are receiving Rituxan for non–Hodgkin’s lymphoma (NHL). Rituxan can cause severe kidney problems that lead to death. Your healthcare provider should do blood tests to check how well your kidneys are working ...
Non-Hodgkin's-lymphoma, treatmentProduct-approvalsRituximab, therapeutic useBACKGROUND: Rituximab, a monoclonal anti-CD20 antibody, in combination with chemotherapy improves overall survival compared to chemotherapy alone when used for induction therapy for patients with newly diagnosed or relapsed indolent ...
Cabanillas, FMcLaughlin, PHagemeister, FRodriguez, M ARomaguera, J EYounes, ASarris, A HPro, BDang, NSamaniego, F
RITUXANTM/CHOP chemo immunotherapy in patients with low- grade or follicular (LG/F) non- Hodgkin s lymphoma(NHL). Czuczman M,Grillo- Lopez AT,White CA,et al. Journal of Immunotherapy . 1997Czuczman, M, Grillo-López, AJ, White, CA (1997) Rituxan/ CHOP chemoimmuno...
Rituxan-Benda-Eam (R-be-EAM) and Rituxan-BEAM (R-BEAM) Have Similar Efficacy in Patients with in B Cell Non-Hodgkin Lymphoma (B-NHL) Patients (Pts) Undergoing Autologous Stem Cell Transplantation (AutoSCT)doi:10.1016/j.bbmt.2016.12.259Nathan, Sunita...
Presents a study which attempted to introduce a series of post-transplant consolidation treatments to address the problem of high relapse rates after autotransplantation for relapsed or refractory lymphoma or Hodgkin's disease. Introduction to combination therapy; Materials and methods used; Results and ...